The Power of $4 bill Drug Ads: Doctors Respond with Diagnosis & Prescription – WashPost Thu, 28 Apr 2005 What does $4 billion dollars in drug advertising buy? The Washington Post reports that a University of Washington study published in the Journal . . . Continue reading →
Vioxx Fallout: Merck Officials Intervened–NYT / FDA Officials Intervened–Mother Jones Mon, 25 Apr 2005 Mother Jones and The New York Times focus on the Vioxx fall out–a case that encapsulates the corrupt practices in drug research. Merck and FDA officials intervened to . . . Continue reading →
UK Pharma Association Displaying Acute Anxiety / FDA approves Focalin XR for ADHD Tue, 14 Jun 2005 The good news is that British physicians are taking a more cautious approach and cutting down on their prescribing of drugs whose adverse side effects . . . Continue reading →
THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) www.ahrp.org Proposed Changes to Subpart D Regulations Increase Risks to Children in Non-Therapeutic Research Statement of the AHRP Opposing the SACHRP Children’s Committee Recommendations April 18, 2005 The Alliance for Human Research Protection (AHRP) welcomes . . . Continue reading →
The Alliance for Human Research Protection (AHRP) welcomes the opportunity to respond to the question “What is the Best Way to Protect Children?”
Our recommendation – which is backed up by evidence that children have suffered harm in medical research – is to significantly limit the discretion of IRBs to approve greater than minimal risk research without direct benefit for the child-subjects under 46.406.
We recommend staying the course in requiring that any such proposed experiment undergo a transparent open evaluation with ample opportunity for public oversight and comment – as required under the provisions of 46.407.
Depressing news for GSK Thu, 14 Apr 2005 A class lawsuit by US investors has been filed against GlaxoSmithKline in the US federal District Court in New York, alleging violation of securities laws. The suit charges GSK issued “false or misleading public . . . Continue reading →
Zyprexa – Risperdal – Abilify – Clozari Kill Elderly Tue, 12 Apr 2005 The long-denied, hidden truth about the deadly risks of antipsychotic drugs is about to be disclosed to the public. The New York Times reports that the FDA will now . . . Continue reading →
NY Times Public Advocate: Extra! Extra! Read Not Quite Everything About It! Sun, 10 Apr 2005 The New York Times Public Editor pointed the finger at the Times for its unprofessional journalistic lapses–such as prematurely publishing scoops planted by one of the . . . Continue reading →
Acting EPA Chief Withdraws Controversial Pesticide Experiment – LAT / NYT Sat, 09 Apr 2005 “We are gratified that when this abominable experiment was exposed to the public, the pesticide industry and its EPA advocates had to surrender." Senator Barbara Boxer has . . . Continue reading →
UK Parliament Report Re: Pharma Influence / US RegulatorsComatose as 258 Fatal Suicides Linked to Neurontin Wed, 6 Apr 2005 The Health Committee of the British House of Commons, has just released its report, “The Influence of the Pharmaceutical Industry.” This landmark . . . Continue reading →
EPA Nominee Challenged in Senate Over Children’s Pesticide Experiment Thu, 07 Apr 2005 AHRP applauds Senator Barbara Boxer for pledging to hold up the confirmation of Stephen Johnson, the President’s nominee to head the Environmental Protection Agency, until he pulls the plug . . . Continue reading →
ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) Promoting Openness, Full Disclosure, and Accountability www.ahrp.org Statement by Vera Hassner Sharav Founder & President, AHRP April 1, 2005 Anthrax Band Reunion Press Conference New York City My name is Vera Hassner Sharav, and I am . . . Continue reading →